{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Little+Rock&page=5&state=Arkansas", "query": { "state": "Arkansas", "city": "Little Rock", "page": 5 }, "page_size": 10 }, "pagination": { "page": 5, "page_size": 10, "total_count": 315, "total_pages": 32, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Little+Rock&page=6&state=Arkansas&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Little+Rock&page=4&state=Arkansas&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-23T23:43:11.626Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00003018", "title": "S9700 Combination Chemotherapy in Treating Patients With Stage II or Stage III Pancreatic Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Pancreatic Cancer" ], "interventions": [ { "name": "dipyridamole", "type": "DRUG" }, { "name": "fluorouracil", "type": "DRUG" }, { "name": "leucovorin calcium", "type": "DRUG" }, { "name": "mitomycin C", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "SWOG Cancer Research Network", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 54, "start_date": "1997-09", "completion_date": "2007-01", "has_results": false, "last_update_posted_date": "2013-01-03", "last_synced_at": "2026-10-23T23:43:11.626Z", "location_count": 84, "location_summary": "Mobile, Alabama • Phoenix, Arizona • Tucson, Arizona + 54 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT00003018" }, { "nct_id": "NCT00005089", "title": "S0014 Combination Chemotherapy Plus Rituximab and Radiation Therapy in Treating Patients With Stage I or Stage II Non-Hodgkin's Lymphoma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Lymphoma" ], "interventions": [ { "name": "rituximab", "type": "BIOLOGICAL" }, { "name": "cyclophosphamide", "type": "DRUG" }, { "name": "doxorubicin hydrochloride", "type": "DRUG" }, { "name": "prednisone", "type": "DRUG" }, { "name": "vincristine sulfate", "type": "DRUG" }, { "name": "radiation therapy", "type": "RADIATION" } ], "intervention_types": [ "BIOLOGICAL", "DRUG", "RADIATION" ], "sponsor": "SWOG Cancer Research Network", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 71, "start_date": "2000-04", "completion_date": "2014-04", "has_results": false, "last_update_posted_date": "2017-01-16", "last_synced_at": "2026-10-23T23:43:11.626Z", "location_count": 92, "location_summary": "Mobile, Alabama • Phoenix, Arizona • Tucson, Arizona + 59 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT00005089" }, { "nct_id": "NCT01975376", "title": "The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Cardiovascular Disease" ], "interventions": [ { "name": "bococizumab (PF-04950615)", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 16784, "start_date": "2013-10-29", "completion_date": "2017-03-22", "has_results": true, "last_update_posted_date": "2018-07-11", "last_synced_at": "2026-10-23T23:43:11.626Z", "location_count": 545, "location_summary": "Athens, Alabama • Birmingham, Alabama • Fort Payne, Alabama + 339 more", "locations": [ { "city": "Athens", "state": "Alabama" }, { "city": "Athens", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT01975376" }, { "nct_id": "NCT00384462", "title": "Study to Evaluate the Incidence of Hospitalizations and Respiratory Tract Infections in Premature Infants", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Respiratory Syncytial Virus Infections" ], "interventions": [], "intervention_types": [], "sponsor": "MedImmune LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Month", "maximum_age": "6 Months", "sex": "ALL", "summary": "1 Month to 6 Months" }, "enrollment_count": 346, "start_date": "2006-10", "completion_date": "2008-01", "has_results": false, "last_update_posted_date": "2009-02-04", "last_synced_at": "2026-10-23T23:43:11.626Z", "location_count": 59, "location_summary": "Birmingham, Alabama • Benton, Arkansas • Jonesboro, Arkansas + 50 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Benton", "state": "Arkansas" }, { "city": "Jonesboro", "state": "Arkansas" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Little Rock", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00384462" }, { "nct_id": "NCT00144027", "title": "Patient-Centered Medication Adherence Intervention for Schizophrenia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Schizophrenia" ], "interventions": [ { "name": "Antipsychotic medication adherence intervention", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "US Department of Veterans Affairs", "sponsor_class": "FED", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 75, "start_date": "2004-12", "completion_date": "2009-07", "has_results": true, "last_update_posted_date": "2015-04-24", "last_synced_at": "2026-10-23T23:43:11.626Z", "location_count": 1, "location_summary": "No. Little Rock, Arkansas", "locations": [ { "city": "No. Little Rock", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00144027" }, { "nct_id": "NCT00430612", "title": "The PACE-MI Registry Study - Outcomes of Beta-blocker Therapy After Myocardial Infarction (OBTAIN)", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Myocardial Infarction" ], "interventions": [], "intervention_types": [], "sponsor": "Northwestern University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "30 Years", "maximum_age": null, "sex": "ALL", "summary": "30 Years and older" }, "enrollment_count": 7057, "start_date": "2009-05", "completion_date": "2015-10", "has_results": false, "last_update_posted_date": "2023-04-24", "last_synced_at": "2026-10-23T23:43:11.626Z", "location_count": 22, "location_summary": "Little Rock, Arkansas • Long Beach, California • Los Angeles, California + 19 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Long Beach", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Bridgeport", "state": "Connecticut" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00430612" }, { "nct_id": "NCT00007683", "title": "Warfarin and Antiplatelet Therapy in Chronic Heart Failure", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Heart Failure" ], "interventions": [ { "name": "Warfarin titrated to an INR of 2.5-3.0", "type": "DRUG" }, { "name": "Aspirin", "type": "DRUG" }, { "name": "Clopidogrel 75", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "US Department of Veterans Affairs", "sponsor_class": "FED", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1587, "start_date": "1998-10", "completion_date": "2004-12", "has_results": false, "last_update_posted_date": "2011-06-16", "last_synced_at": "2026-10-23T23:43:11.626Z", "location_count": 79, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Tucson, Arizona + 76 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "No. Little Rock", "state": "Arkansas" }, { "city": "Downey", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00007683" }, { "nct_id": "NCT00012363", "title": "S0101 Gemcitabine and Irinotecan in Treating Patients With Metastatic or Recurrent Cancer of the Esophagus", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Esophageal Cancer", "Gastric Cancer" ], "interventions": [ { "name": "gemcitabine hydrochloride", "type": "DRUG" }, { "name": "irinotecan hydrochloride", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "SWOG Cancer Research Network", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 61, "start_date": "2001-04", "completion_date": "2006-04", "has_results": false, "last_update_posted_date": "2012-06-14", "last_synced_at": "2026-10-23T23:43:11.626Z", "location_count": 96, "location_summary": "Mobile, Alabama • Phoenix, Arizona • Tucson, Arizona + 61 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT00012363" }, { "nct_id": "NCT06435221", "title": "Safety Study of Cytisinicline in Adult Combustible and/or E-cigarette Smokers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Smoking Cessation", "Vaping Cessation" ], "interventions": [ { "name": "Cytisinicline", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Achieve Life Sciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 479, "start_date": "2024-05-28", "completion_date": "2025-10-06", "has_results": false, "last_update_posted_date": "2025-11-26", "last_synced_at": "2026-10-23T23:43:11.626Z", "location_count": 29, "location_summary": "Mobile, Alabama • Tempe, Arizona • Little Rock, Arkansas + 26 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Tempe", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Coral Gables", "state": "Florida" }, { "city": "DeLand", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT06435221" }, { "nct_id": "NCT03579641", "title": "Precision Event Monitoring for Patients With Heart Failure Using HeartLogic", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Heart Failure", "Defibrillators, Implantable", "Monitoring, Physiologic", "Cardiac Resynchronization Therapy", "Cardiovascular Disease", "Heart Disease" ], "interventions": [ { "name": "HeartLogic Sensors", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Boston Scientific Corporation", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 2184, "start_date": "2018-06-01", "completion_date": "2021-10-29", "has_results": false, "last_update_posted_date": "2022-10-25", "last_synced_at": "2026-10-23T23:43:11.626Z", "location_count": 56, "location_summary": "Birmingham, Alabama • Jonesboro, Arkansas • Little Rock, Arkansas + 48 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Jonesboro", "state": "Arkansas" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Burbank", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03579641" } ] }